聯合醫務(00722.HK)獲主席孫耀江及執董李家聰合計增持1500萬股
格隆匯5月26日丨聯合醫務(00722.HK)發佈公吿,公司董事會主席兼行政總裁孫耀江於2021年5月20日在市場上收購500萬股公司股份,總代價約325萬港元(相當於平均價格每股股份約0.65港元)。
此外,公司執行董事李家聰於2021年5月14日及2021年5月20日先後在市場上收購合共1000萬股公司股份,總代價約650萬港元(相當於平均價格每股股份約0.65港元)(連同孫耀江收購統稱“收購事項”)。
由於上述收購事項,於公吿日期,孫耀江擁有合共2.75億股股份的權益,佔公司全部已發行股本約35.52%,而李家聰擁有合共2463萬股股份的權益,佔公司全部已發行股本約3.18%。彼等各自的持股亦包括尚未行使的購股權。
除收購事項外,多名董事於2021年第一及第二季度內亦一直增持公司的股權。
展望未來,公司致力透過線上和線下服務將客户和患者的體驗以及彼此之間的互動實現數碼轉型,在此推動下,利用公司於中國內地的互聯網醫院牌照,公司將引領現有業務模式的拓展並提升服務的質素和範圍。包括孫耀江和李家聰在內的董事增持股權,足證董事會對公司前景和內在價值充滿信心,亦印證彼等對公司的長遠承諾。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.